×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.

Publications

ADNI publication pdfs can be searched by author, keyword, or
PMCID using the ADNI PDF search above.

Filter results by:
Year Range:

-
Journal
Authors

1739 Total Publications

The Alzheimer’s Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
Beckett, L. a., Harvey, D. J., Gamst, A., Donohue, M., Kornak, J., Zhang, H., & Kuo, J. H.
PMID: 20451874 ; PMCID:2867839 ; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 3; pp. 257-264; doi:10.1016/j.jalz.2010.03.002
Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline
Chou, Y.-Y., Leporé, N., Saharan, P., Madsen, S. K., Hua, X., Jack, C. R., … Thompson, P. M.
PMID: 20620663 ; PMCID:2904619 ; 2010; Journal Neurobiology of Aging; vol. 31; no. 8; pp. 1386-400; doi:10.1016/j.neurobiolaging.2010.05.001
Comparing predictors of conversion and decline in mild cognitive impairment
Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., … Jagust, W. J.
PMID: 20592257 ; PMCID:2906178 ; 2010; Journal Neurology; vol. 75; no. 3; pp. 230-238; doi:10.1212/WNL.0b013e3181e8e8b8
Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer’s disease
Xu, C., Wang, Z., Fan, M., Liu, B., Song, M., Zhen, X., & Jiang, T.
PMID: 20613678 ; PMCID:2954459 ; 2010; Journal Neuroreport; vol. 21; no. 12; pp. 802-7; doi:10.1097/WNR.0b013e32833ccaf4
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe CC1, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL
PMID: 20472326 ; 2010; Journal Neurobiol Aging; vol. 31; no. 8; pp. 1275-83; doi:10.1016/j.neurobiolaging.2010.04.007
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
Schneider, L. S., Kennedy, R. E., & Cutter, G. R.
PMID: 21414558 ; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 5; pp. 367-77; doi:10.1016/j.jalz.2010.07.004
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: A longitudinal MRI study.
Tosun, D., Schuff, N., Truran-Sacrey, D., Shaw, L. M., Trojanowski, J. Q., Aisen, P., … Weiner, M. W.
2010; Journal Neurobiology of Aging; vol. 31; no. 8; pp. 1340-1354; doi:10.1016/j.neurobiolaging.2010.04.030
The Alzheimer's disease neuroimaging initiative: perspectives of the Industry Scientific Advisory Board
Schmidt ME1, Siemers E, Snyder PJ, Potter WZ, Cole P, Soares H.
PMID: 20451878 ; 2010; Journal Alzheimers Dement; vol. 6; no. 3; pp. 286-90; doi:10.1016/j.jalz.2010.03.010
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
Schneider, L. S., Kennedy, R. E., & Cutter, G. R.
PMID: 21414558 ; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 5; pp. 367-77; doi:10.1016/j.jalz.2010.07.004
Discovery and use of efficient biomarkers for objective disease state assessment in Alzheimer’s disease
van Gils M1, Koikkalainen J, Mattila J, Herukka S, Lotjonen J, Soininen H.
PMID: 21095977 ; 2010; Journal Int J Geriatr Psychiatry; vol. 30; no. 2; pp. 192-200; doi:10.1109/IEMBS.2010.5626311